5, December 2019
Health group withdraws staff from Congo-Kinshasa amid violence 0
The non-profit group Doctors without Borders (MSF) pulled its foreign staff out of an eastern region of the Democratic Republic of the Congo after an armed group tried to enter its compound.
The group is the latest aid agency to withdraw its staff from the Biakato region, after three health workers treating Ebola were killed in an unclaimed attack last week at an accommodation camp in Biakato Mines in Ituri Province.
That attack prompted the World Health Organization to withdraw its staff from the area.
MSF said that on Tuesday night, a group wielding machetes and sticks broke into the Biakato Health Center, where it operates an Ebola Treatment Center. There were no casualties and the group did not enter the Ebola facility, it said.
A separate group with the same weapons then tried but failed to enter the MSF facility in Biakato Mines. The NGO said they threw stones but did not do any damage.
“Due to a deterioration in the security situation, MSF made the difficult decision to withdraw all non-local staff from the Biakato region,” MSF said in a statement.
According to local authorities, the attackers from last week’s incident are likely to be members of the Mayi-Mayi armed militia group, which is fighting for a share of the country’s wealth.
The DRC is undergoing its 10th Ebola epidemic, which is the second-deadliest on record.
The death toll from an Ebola outbreak in eastern Democratic Republic of Congo has risen to more than 200.
An outbreak of the much-feared hemorrhagic virus has killed 2,206 people mainly in North Kivu and neighboring Ituri, according to the latest official figures.
Insecurity has complicated the epidemic from the outset, compounding resistance within communities to preventive measures, care facilities, and safe burials.
On November 4, the authorities said more than 300 attacks on Ebola health workers had been recorded since the start of the year, leaving six dead and 70 wounded, some of them patients.
(Source: AFP)



















6, December 2019
Japan launches human trial of new Ebola vaccine 0
Japanese scientists will begin the country’s first human trial for a new vaccine against the deadly Ebola virus this month, they said Friday.
The vaccine, which has previously been tested in monkeys, uses an inactivated form of the virus that can only effectively replicate in artificial cells.
Scientists hope that will make it safer than other treatments, the Institute of Medical Science at the University of Tokyo said in a press release.
“We think there’s high hope for a new, safe vaccine which can be produced effectively,” Yoshihiro Kawaoka, a professor of infectious diseases at the university who helped developed the vaccine, said in the release.
The university will begin the clinical study later in December, injecting 30 healthy adult men with two doses of the vaccine, four weeks apart.
They will be monitored for side effects and whether they have developed immunity to Ebola.
The Ebola virus is passed on by contact with the blood, body fluids, secretions or organs of an infected or recently deceased person.
The death rate is typically high, ranging up to 90 percent in some outbreaks, according to the WHO.
Several Ebola vaccines exist, including rVSV-ZEBOV and a new formula produced by a Belgian subsidiary of Johnson & Johnson that went into use last month in the Democratic Republic of Congo.
The country is in the grip of an Ebola epidemic that has killed more than 2,000 people in 15 months.
It is the second most deadly to date after a 2014-2016 outbreak which left some 11,000 people dead and underscored the urgency to bring a vaccine to market.
The current outbreak is the tenth in the country since its first in 1976.
Source: AFP